Sovaldi
Feb 14, 2018
Gilead Sciences Introduces Sovaldi: A Potent Hepatitis C Treatment
Gilead Sciences has recently launched a highly effective hepatitis C drug Sovaldi at a whopping price of USD 84,000 per treatment course at the same time when ‘How to price a cure’ discussion has entered the pharma industry. Gilead bought a launch-ready drug and launched it very quietly hoping that it's very cost-ef...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
